Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition

Contrary to initial expectations, angiogenesis inhibitors can cause toxicities in patients with cancer. The toxicity profiles of these inhibitors reflect the disturbance of growth factor signalling pathways that are important for maintaining homeostasis. Experiences with angiogenesis inhibitors in c...

Full description

Saved in:
Bibliographic Details
Published inNature reviews. Cancer Vol. 7; no. 6; pp. 475 - 485
Main Authors Pinedo, Herbert M, Verheul, Henk. M. W
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.06.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Contrary to initial expectations, angiogenesis inhibitors can cause toxicities in patients with cancer. The toxicity profiles of these inhibitors reflect the disturbance of growth factor signalling pathways that are important for maintaining homeostasis. Experiences with angiogenesis inhibitors in clinical trials indicate that short-term toxicities are mostly manageable. However, these agents will also be given in prolonged treatment strategies, so we need to anticipate possible long-term toxicities. In addition, understanding the molecular mechanisms involved in the toxicity of angiogenesis inhibition should allow more specific and more potent inhibitors to be developed.
ISSN:1474-175X
1474-1768
DOI:10.1038/nrc2152